Related Experiment Video

Updated: Aug 10, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Sensitization for anticancer drug-induced apoptosis by betulinic Acid

Simone Fulda1, Klaus-Michael Debatin

  • 1University Children's Hospital, Prittwitzstrasse 43, Ulm 89075, Germany. simone.fulda@medizin.uni-ulm.de

Neoplasia (New York, N.Y.)
|April 2, 2005
PubMed

Insights

Betulinic acid (BetA) enhances chemotherapy by sensitizing tumor cells to apoptosis and inhibiting survival. This natural compound, combined with anticancer drugs, targets the mitochondrial pathway, showing promise for novel cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Betulinic acid (BetA), a natural pentacyclic triterpenoid, is known to induce apoptosis in tumor cells via the mitochondrial pathway.
  • The potential of BetA as a sensitizer in combination cancer therapy remains largely unexplored.

Purpose of the Study:

  • To investigate the synergistic effects of BetA in combination with conventional anticancer drugs.
  • To elucidate the mechanisms underlying the cooperative induction of apoptosis and inhibition of tumor cell survival.

Main Methods:

  • Co-treatment of various tumor cell lines with BetA and different anticancer agents (doxorubicin, cisplatin, Taxol, VP16, actinomycin D).
  • Assessment of apoptosis induction, clonogenic survival, mitochondrial membrane potential, and cytochrome c/Smac release.
  • Evaluation of the role of Bcl-2 in mediating the cooperative effects.

Main Results:

  • BetA demonstrated synergistic effects with multiple anticancer drugs, enhancing apoptosis and inhibiting clonogenic survival across diverse tumor cell lines, including p53 mutant and primary tumor cells.
  • Combined treatment induced mitochondrial pathway perturbations, including loss of membrane potential and release of cytochrome c and Smac, leading to caspase activation.
  • Overexpression of Bcl-2 counteracted these effects, confirming the involvement of the mitochondrial pathway.
  • The cooperative effects were tumor-specific, with minimal impact on human fibroblasts.

Conclusions:

  • Betulinic acid acts as a potent sensitizer, enhancing the efficacy of various anticancer drugs through the mitochondrial apoptosis pathway.
  • Combination therapy with BetA offers a promising novel strategy for improving anticancer treatment outcomes.
  • Further investigation into BetA-based combination regimens is warranted for clinical application.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...